How the environment shapes cancer genomes

Current Opinion in Oncology

Volumn 27, Issue 1, 2015, Pages 71-77

  Pfeifer, Gerd P ^a,b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Esophageal cancer; Liver cancer; Lung cancer; Melanoma; Mutations

Indexed keywords

ARISTOLOCHIC ACID; CARCINOGEN;

DNA DAMAGE; ENVIRONMENTAL EXPOSURE; ESOPHAGEAL ADENOCARCINOMA; GENE MUTATION; GENOME; HIGH THROUGHPUT SEQUENCING; HUMAN; LIVER CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MELANOMA SKIN CANCER; MUTATION RATE; OCCUPATIONAL EXPOSURE; RADIATION EXPOSURE; REVIEW; SMOKING; STUDY; TRANSITIONAL CELL CARCINOMA; ULTRAVIOLET B RADIATION; ADVERSE EFFECTS; DNA SEQUENCE; GENETICS; MUTAGENESIS; MUTATION; NEOPLASMS;

CARCINOGENS; ENVIRONMENTAL EXPOSURE; HUMANS; MUTAGENESIS; MUTATION; NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 84916878568     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0000000000000152     Document Type: Review

References (60)

1. Luch A. Nature and nurture -lessons from chemical carcinogenesis. Nat Rev Cancer 2005; 5: 113-125.
2. Rusch HP, Baumann CA. Tumor production in mice with ultraviolet radiation. Am J Cancer 1939; 35: 55-62.
3. Croninger AB, Graham EA, Wynder EL. Experimental production of carcinoma with tobacco products. V. Carcinoma induction in mice with cigar, pipe, and all-tobacco cigarette tar. Cancer Res 1958; 18: 1263-1271.
4. Winkelmann RK, Baldes EJ, Zollman PE. Squamous cell tumors induced in hairless mice with ultraviolet light. J Invest Dermatol 1960; 34: 131-138.
5. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 Mutations in human cancers. Science 1991; 253: 49-53.
6. Petitjean A, Mathe E, Kato S, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database. Hum Mutat 2007; 28: 622-629.
7. Leroy B, Anderson M, Soussi T. TP53 mutations in human cancer: Database reassessment and prospects for the next decade. Hum Mutat 2014; 35: 672-688.
8. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88: 10124-10128.
9. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 429-431.
10. Hsu IC, Metcalf RA, Sun T, et al. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427-428.
11. Ortiz-Cuaran S, Villar S, Gouas D, et al. Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand. Cancer Lett 2013; 331: 46-51.
12. Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: Origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2010; 2: A001008.
13. Pfeifer GP, Denissenko MF, Olivier M, et al. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-Associated cancers. Oncogene 2002; 21: 7435-7451.
14. Hainaut P, Pfeifer GP. Patterns of p53 GT transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001; 22: 367-374.
15. Denissenko MF, Pao A, Tang M-S, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996; 274: 430-432.
16. Vogelstein B, Papadopoulos N, Velculescu VE, et al. Cancer genome landscapes. Science 2013; 339: 1546-1558.
17. Helleday T, Eshtad S, Nik-Zainal S. Mechanisms underlying mutational signatures in human cancers. Nat Rev Genet 2014; 15: 585-598.
18. Alexandrov LB, Stratton MR. Mutational signatures: The patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev 2014; 24: 52-60.
19. Lawrence MS, Stojanov P, Polak P, et al. Mutational heterogeneity in cancer and the search for new cancer-Associated genes. Nature 2013; 499: 214-218.
20. Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature 2013; 500: 415-421.
21. Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Deciphering signatures of mutational processes operative in human cancer. Cell Rep 2013; 3: 246-259.
22. Pfeifer GP. Mutagenesis at methylated CpG sequences. Curr Top Microbiol Immunol 2006; 301: 259-281.
23. Pfeifer GP, Kadam S, Jin SG. 5-Hydroxymethylcytosine and its potential roles in development and cancer. Epigenetics Chromatin 2013; 6: 10.
24. Nik-Zainal S, Alexandrov LB, Wedge DC, et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012; 149: 979-993.
25. Kuong KJ, Loeb LA. APOBEC3B mutagenesis in cancer. Nat Genet 2013; 45: 964-965.
26. Hanawalt PC, Spivak G. Transcription-coupled DNA repair: Two decades of progress and surprises. Nat Rev Mol Cell Biol 2008; 9: 958-970.
27. Denissenko MF, Pao A, Pfeifer GP, Tang M-S. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers. Oncogene 1998; 16: 1241-1247.
28. Pleasance ED, Cheetham RK, Stephens PJ, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010; 463: 191-196.
29. Pleasance ED, Stephens PJ, O'Meara S, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010; 463: 184-190.
30. Polak P, Lawrence MS, Haugen E, et al. Reduced local mutation density in regulatory DNA of cancer genomes is linked to DNA repair. Nat Biotechnol 2014; 32: 71-75.
31. Tu Y, Tornaletti S, Pfeifer GP. DNA repair domains within a human gene: Selective repair of sequences near the transcription initiation site. EMBO J 1996; 15: 675-683.
32. Mitchell D, Fernandez A. The photobiology of melanocytes modulates the impact of UVA on sunlight-induced melanoma. Photochem Photobiol Sci 2012; 11: 69-73.
33. Pfeifer GP, Besaratinia A. UV wavelength-dependent DNA damage and human nonmelanoma and melanoma skin cancer. Photochem Photobiol Sci 2012; 11: 90-97.
34. De Fabo EC, Noonan FP, Fears T, Merlino G. Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res 2004; 64: 6372-6376.
35. Berger MF, Hodis E, Heffernan TP, et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 2012; 485: 502-506.
36. Nikolaev SI, Rimoldi D, Iseli C, et al. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet 2012; 44: 133-139.
37. Krauthammer M, Kong Y, Ha BH, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 2012; 44: 1006-1014.
38. Gartner JJ, Parker SC, Prickett TD, et al. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc Natl Acad Sci USA 2013; 110: 13481-13486.
39. Hecht SS. Lung carcinogenesis by tobacco smoke. Int J Cancer 2012; 131: 2724-2732.
40. Kandoth C, McLellan MD, Vandin F, et al. Mutational landscape and significance across 12 major cancer types. Nature 2013; 502: 333-339.
41. Govindan R, Ding L, Griffith M, et al. Genomic landscape of nonsmall cell lung cancer in smokers and never-smokers. Cell 2012; 150: 1121-1134.
42. Imielinski M, Berger AH, Hammerman PS, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 2012; 150: 1107-1120.
43. Yoon JH, Smith LE, Feng Z, et al. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide inmammalian cells: Similarities with the p53 mutation spectrum in smoking-Associated lung cancers. Cancer Res 2001; 61: 7110-7117.
44. Agrawal N, Jiao Y, Bettegowda C, et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov 2012; 2: 899-905.
45. Dulak AM, Stojanov P, Peng S, et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet 2013; 45: 478-486.
46. Schmeiser HH, Nortier JL, Singh R, et al. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy. Int J Cancer 2014; 135: 502-507.
47. Arlt VM, Schmeiser HH, Pfeifer GP. Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferasedependent PCR. Carcinogenesis 2001; 22: 133-140.
48. Grollman AP, Shibutani S, Moriya M, et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci USA 2007; 104: 12129-12134.
49. Liu Z, Hergenhahn M, Schmeiser HH, et al. Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene. Proc Natl Acad Sci USA 2004; 101: 2963-2968.
50. Hoang ML, Chen CH, Sidorenko VS, et al. Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci Transl Med 2013; 5: 197-102.
51. Poon SL, Pang ST, McPherson JR, et al. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Sci Transl Med 2013; 5: 197-101.
52. Fujimoto A, Totoki Y, Abe T, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 2012; 44: 760-764.
53. Totoki Y, Tatsuno K, Yamamoto S, et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet 2011; 43: 464-469.
54. Huang J, Deng Q, Wang Q, et al. Exome sequencing of hepatitis B virusassociated hepatocellular carcinoma. Nat Genet 2012; 44: 1117-1121.
55. Guichard C, Amaddeo G, Imbeaud S, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012; 44: 694-698.
56. Shibata T, Aburatani H. Exploration of liver cancer genomes. Nat Rev Gastroenterol Hepatol 2014; 11: 340-349.
57. Yoon JH, Besaratinia A, Feng Z, et al. DNA damage, repair, and mutation induction by ()-Syn and (-)-Antidibenzo[a, l]pyrene-11, 12-diol-13, 14-epoxides in mouse cells. Cancer Res 2004; 64: 7321-7328.
58. Jackson MA, Lea I, Rashid A, et al. Genetic alterations in cancer knowledge system: Analysis of gene mutations in mouse and human liver and lung tumors. Toxicol Sci 2006; 90: 400-418.
59. Meier B, Cooke SL, Weiss J, et al. C. elegans whole genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency. Genome Res 2014; 24: 1624-1636.
60. Kennedy SR, Salk JJ, Schmitt MW, Loeb LA. Ultra-sensitive sequencing reveals an age-related increase in somatic mitochondrial mutations that are inconsistent with oxidative damage. PLoS Genet 2013; 9: E1003794.